Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
2(12%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
6%
Ph phase_1
9
53%
Ph phase_2
5
29%
Ph phase_4
2
12%

Phase Distribution

9

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
9(52.9%)
Phase 2Efficacy & side effects
5(29.4%)
Phase 3Large-scale testing
1(5.9%)
Phase 4Post-market surveillance
2(11.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

17

all time

Status Distribution
Active(4)
Completed(10)
Other(3)

Detailed Status

Completed10
unknown3
Recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
17
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 19 (52.9%)
Phase 25 (29.4%)
Phase 31 (5.9%)
Phase 42 (11.8%)

Trials by Status

recruiting212%
unknown318%
completed1059%
not_yet_recruiting212%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07569198Phase 2

Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)

Not Yet Recruiting
NCT06496750Phase 2

Ketamine for Methamphetamine Use Disorder

Recruiting
NCT06867068Phase 1

Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery

Completed
NCT05004896Phase 2

Ketamine for Treatment-Resistant Bipolar Disorder

Completed
NCT06480500Phase 2

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Recruiting
NCT04592809Phase 3

Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents

Completed
NCT03556592Phase 1

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Completed
NCT06090422Phase 1

Ketamine for Combined Depression and Alcohol Use Disorder

Not Yet Recruiting
NCT02992496Phase 2

Investigation of Antidepressant Efficacy of Oral Ketamine Treatment

Unknown
NCT03330990Phase 1

Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients

Completed
NCT03457597Phase 1

Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s

Completed
NCT02985697Phase 4

Safety and Efficacy of Intranasal Dexmedetomidine

Unknown
NCT02953210Phase 4

Laparoscopic Cholecystectomy: General Anesthesia With Opioid Versus General Opioid Free Anesthesia

Unknown
NCT00142493Phase 1

Effect of Affective Content on Drug Induced Amnesia of Episodic Memory

Completed
NCT02473627Phase 1

A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

Completed
NCT01218620Phase 1

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

Completed
NCT02256813Phase 1

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17